Purchase Order 36C24424P0468

Award Date 5/1/24
Potential Completion Date 4/30/29
Potential Value $1.7M
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15240, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., provides PET/CT radiopharmaceuticals to the Department of Veterans Affairs (VA). The $2,343,583.08 fixed-price contract was set aside for small businesses and is scheduled for completion by September 30, 2023. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with extensive experience in positron emission tomography (PET) imaging. The company has been a key provider of...
This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
This contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $171,500.00 firm fixed-price purchase order has an ultimate completion date of April 4, 2019 and was awarded on October 1, 2016. This contract is not set aside and is part of Sofie's broader portfolio of federal contracts and indefinite delivery vehicles (IDVs) to supply specialized radiopharmaceuticals, including PET imaging agents and...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
This is a federal contract award to Sofie CO., doing business as Sofie, a for-profit organization specializing in the development and delivery of molecular diagnostics and therapeutics. The $80,750 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) to provide PET (Positron Emission Tomography) pharmaceuticals. The contract is part of the VA's VISN 4 (Veterans Integrated Service Network 4) program and has an ultimate completion date of December 30, 2019. Sofie has...
This federal contract award to Sofie CO. is for the provision of nuclear medicine PET radioisotopes to the Department of Veterans Affairs (VA) Veterans Health Administration in Veterans Integrated Service Network 21. The $136,876.00 firm-fixed-price purchase order does not have a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics. The company has received numerous federal contract awards from the...
This federal contract award is for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, with a ceiling value of $751,599.72, was awarded to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals and positron emission tomography (PET) imaging agents. The company has...

This is a federal contract award to Sofie CO., doing business as IBA Molecular, a subsidiary of Sofie Biosciences, Inc. The $1,725,507.80 fixed-price contract was awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) for the supply of FDG and NEURACEQ radiopharmaceuticals. This contract does not have a set-aside designation.

Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals and positron emission tomography (PET) imaging agents. The company has established itself as a key supplier of these critical medical imaging products to federal healthcare agencies, including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH). This contract is part of Sofie's broader portfolio of federal contract awards and Indefinite Delivery Vehicles (IDVs) for the provision of radiopharmaceuticals and related services to support medical imaging and cancer treatment programs for veterans and military personnel across multiple healthcare facilities.

Generated 7/26/25, 11:38 AM